These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912 [TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy. Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640 [TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy. Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958 [TBL] [Abstract][Full Text] [Related]
6. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization. Cheung C; Patel HD; Landis P; Carter HB; Han M Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study. Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK. Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680 [TBL] [Abstract][Full Text] [Related]
10. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398 [TBL] [Abstract][Full Text] [Related]
11. Preprostate Biopsy Rectal Culture and Postbiopsy Sepsis. Taylor AK; Murphy AB Urol Clin North Am; 2015 Nov; 42(4):449-58. PubMed ID: 26475942 [TBL] [Abstract][Full Text] [Related]
12. Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies? Gopal Rao G; Batura D Int Urol Nephrol; 2014 Feb; 46(2):309-15. PubMed ID: 23934620 [TBL] [Abstract][Full Text] [Related]
13. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli. Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574 [TBL] [Abstract][Full Text] [Related]
14. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study. Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study. Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300 [TBL] [Abstract][Full Text] [Related]
16. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study. Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053 [TBL] [Abstract][Full Text] [Related]
17. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital. Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990 [TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957 [TBL] [Abstract][Full Text] [Related]
19. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416 [TBL] [Abstract][Full Text] [Related]